WARD International Pilot Studies

Study design

This study will be an international multicentre prospective observational pilot study assessing the functionality and user experience of a new vital sign monitoring system.

Sample size

Each site can include up to 20 patients during the 3-month study period.

Study Sites

The Cleveland Clinic, Ohio, USA

University Medical Center Hamburg-Eppendorf, Germany

The Royal Liverpool University Hospital, UK

Skt. Olav Hospital Trondheim, Norway

University Medical Centre Groningen, The Netherlands

Inclusion criteria

Adults (≥18 years)

Expected stay in the hospital ≥2 days

Admitted for surgery with expected duration of surgery >2 hours or admitted for acute medical condition with at least one of the following vital sign deviations within 24 hours of acute admission, recorded by the staff

• RF >21 breaths pr minute
• RF < 11 breaths pr minute
• P > 91 beats pr minute
• P < 50 beats pr minute
• SpO2 < 94 % without oxygen supplementation
• Systolic BP < 110 mmHg
• Systolic BP > 220 mmHg

Study Procedures

20 Patients in the general ward (surgical or medical) will be monitored with wCVSM and answer a questionnaire afterwards. 20 nurses will answer a questionnaire after having had the responsibility for a monitored patient for a full shift (including a shift where monitoring is initiated or a shift where the patient is discharged). Therefore, multiple nurses can be interviewed per patient. Patients will in addition have vital signs monitored as per standard practice. Participants will be recruited from wards at the study sites.

Frequency of alerts activated in the app in relation to the alerts that should be activated based on measured data